Evidence map›Paper›PMID 32277908›Full record

ArticleThe Lancet. Infectious diseases2020

Association between the proportion of Plasmodium falciparum and Plasmodium vivax infections detected by passive surveillance and the magnitude of the asymptomatic reservoir in the community: a pooled analysis of paired health facility and community data.

Gillian Stresman, Nuno Sepúlveda, Kimberly Fornace, Lynn Grignard, Julia Mwesigwa, Jane Achan, John Miller, Daniel J Bridges, Thomas P Eisele, Jacklin Mosha and 30 more

Open access · bronzeAbstract read
In one paragraph

Article in The Lancet. Infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Accelerating towardsLancet regional health. Americas · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Sustainable Surveillance of Neglected Tropical Diseases for the Post-Elimination Era.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

40 authors at 20 institutions in 17 countries.

Gillian StresmanDepartment of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: gillian.stresman@lshtm.ac.uk.
Nuno SepúlvedaDepartment of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK; Centre of Statistics and Its Applications, University of Lisbon, Lisbon, Portugal.
Kimberly FornaceDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.
Lynn GrignardDepartment of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK.
Julia MwesigwaMedical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia; Department of Global Health, University of Antwerp, Antwerp, Belgium.
Jane AchanMedical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
John MillerPATH Malaria Control and Elimination Partnership in Africa (MACEPA), National Malaria Elimination Centre, Ministry of Health, Chainama Grounds Lusaka, Zambia.
Daniel J BridgesPATH Malaria Control and Elimination Partnership in Africa (MACEPA), National Malaria Elimination Centre, Ministry of Health, Chainama Grounds Lusaka, Zambia.
Thomas P EiseleCenter for Applied Malaria Research and Evaluation, Department of Tropical Medicine, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA.
Jacklin MoshaNational Institute for Medical Research, Mwanza Medical Research Centre, Mwanza, Tanzania.
Pauline Joy LorenzoDepartment of Parasitology, Research Institute for Tropical Medicine, Research Drive, Alabang, Muntinlupa, Metro Manila, Philippines.
Maria Lourdes MacalinaoDepartment of Parasitology, Research Institute for Tropical Medicine, Research Drive, Alabang, Muntinlupa, Metro Manila, Philippines.
Fe Esperanza EspinoDepartment of Parasitology, Research Institute for Tropical Medicine, Research Drive, Alabang, Muntinlupa, Metro Manila, Philippines.
Fitsum TadesseDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Jennifer C StevensonMacha Research Trust, Choma District, Zambia; Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Antonio M QuispeSchool of Medicine, Universidad Continental, Huancayo, Peru.
André SiqueiraFundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil; Programa de Pós-graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Marcus LacerdaFundacao de Medicine Tropical Dr. Heitor Viera Dourado, Manaus, Brazil; Institutos Nacionais de Ciencia e Technologia (INCT), Instituto Elimina, Manaus, Brazil.
Shunmay YeungDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Siv SovannarothNational Center for Parasitology, Entomology and Malaria Control, Phnom Penh, Cambodia.
Emilie PothinDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland; Clinton Health Access Initiative, Boston, MA, USA.
Joanna GallayDepartment of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.
Karen E HamreCenters for Disease Control and Prevention, Center for Global Health, Division of Parasitic Diseases and Malaria, Malaria Branch, Atlanta, GA, USA; CDC Foundation, Atlanta, GA, USA.
Alyssa YoungClinton Health Access Initiative, Port-au-Prince, Haiti.
Jean Frantz LemoineProgramme National de Contrôle de la Malaria, Ministère de la Santé Publique et de la Population (MSPP), Port-au-Prince, Haiti.
Michelle A ChangCenters for Disease Control and Prevention, Center for Global Health, Division of Parasitic Diseases and Malaria, Malaria Branch, Atlanta, GA, USA.
Koukeo PhommasoneLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos.
Mayfong MayxayLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Institute of Research and Education Development, University of Health Sciences, Vientiane, Laos.
Jordi LandierAix Marseille Univ, IRD, INSERM, SESSTIM, Marseille, France.
Daniel M ParkerDepartment of Population Health and Disease Prevention and Department of Epidemiology, University of California, Irvine, CA, USA.
Lorenz Von SeidleinOxford Tropical Medicine Research Unit, Mahidol University Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Francois NostenCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Shoklo Malaria Research Unit, Mae Sot, Thailand.
Gilles DelmasCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Shoklo Malaria Research Unit, Mae Sot, Thailand.
Arjen DondorpOxford Tropical Medicine Research Unit, Mahidol University Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Ewan CameronTelethon Kids Institute, Perth Children's Hospital, Nedlands, WA, Australia; Curtin University, Bentley, WA, Australia.
Katherine BattleInstitute for Disease Modelling, Seattle, WA, USA.
Teun BousemaDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, Netherlands.
Peter GethingTelethon Kids Institute, Perth Children's Hospital, Nedlands, WA, Australia; Curtin University, Bentley, WA, Australia.
Umberto D'AlessandroDepartment of Disease Control, London School of Hygiene & Tropical Medicine, London, UK; Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia.
Chris DrakeleyDepartment of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK.
London School of Hygiene & Tropical Medicine · GBUniversity of Oxford · GBResearch Institute for Tropical Medicine · PHMinistry of Health · ZMSwiss Tropical and Public Health Institute · CHCambodia National Malaria Center · KHCenter for Global Health · USCenters for Disease Control and Prevention · USFundação de Medicina Tropical · BRInserm · FRInstitute for Disease Modeling · USInstituto Evandro Chagas · BRJohns Hopkins University · USLao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit · LAMahidol University · THMRC Unit the Gambia · GMNational Institute for Medical Research · TZPrincess Margaret Hospital for Children · AURadboud University Medical Center · NLRadboud University Nijmegen · NL

Funding

Medical Research Council MC_EX_MR/J002364/1Wellcome Trust 204693/Z/16/Z
6 · The paper itself

Abstract

backgroundPassively collected malaria case data are the foundation for public health decision making. However, because of population-level immunity, infections might not always be sufficiently symptomatic to prompt individuals to seek care. Understanding the proportion of all Plasmodium spp infections expected to be detected by the health system becomes particularly paramount in elimination settings. The aim of this study was to determine the association between the proportion of infections detected and transmission intensity for Plasmodium falciparum and Plasmodium vivax in several global endemic settings.

methodsThe proportion of infections detected in routine malaria data, P(Detect), was derived from paired household cross-sectional survey and routinely collected malaria data within health facilities. P(Detect) was estimated using a Bayesian model in 431 clusters spanning the Americas, Africa, and Asia. The association between P(Detect) and malaria prevalence was assessed using log-linear regression models. Changes in P(Detect) over time were evaluated using data from 13 timepoints over 2 years from The Gambia.

findingsThe median estimated P(Detect) across all clusters was 12·5% (IQR 5·3-25·0) for P falciparum and 10·1% (5·0-18·3) for P vivax and decreased as the estimated log-PCR community prevalence increased (adjusted odds ratio [OR] for P falciparum 0·63, 95% CI 0·57-0·69; adjusted OR for P vivax 0·52, 0·47-0·57). Factors associated with increasing P(Detect) included smaller catchment population size, high transmission season, improved care-seeking behaviour by infected individuals, and recent increases (within the previous year) in transmission intensity.

interpretationThe proportion of all infections detected within health systems increases once transmission intensity is sufficiently low. The likely explanation for P falciparum is that reduced exposure to infection leads to lower levels of protective immunity in the population, increasing the likelihood that infected individuals will become symptomatic and seek care. These factors might also be true for P vivax but a better understanding of the transmission biology is needed to attribute likely reasons for the observed trend. In low transmission and pre-elimination settings, enhancing access to care and improvements in care-seeking behaviour of infected individuals will lead to an increased proportion of infections detected in the community and might contribute to accelerating the interruption of transmission.

fundingWellcome Trust.

Indexed as

AdolescentAdultAfricaAgedAged, 80 and overAmericasAsiaAsymptomatic InfectionsBayes TheoremChildChild, PreschoolCluster AnalysisCross-Sectional StudiesDisease ReservoirsFemaleHealth Facilities

Identifiers

PMID32277908
PMCPMC7391005
OpenAlexW3008212975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.